Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Linperlisib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 1702816-75-8, Pi3kdelta-in-2, Pi3k(delta)-in-2, 05hyk3cv9n, Yy-20394, Pi3k
    Molecular Formula
    C28H37FN6O5S
    Molecular Weight
    588.7  g/mol
    InChI Key
    NVWKNQGHVMMAJW-UHFFFAOYSA-N
    FDA UNII
    05HYK3CV9N
    Linperlisib is an orally available selective inhibitor of the delta form of phosphatidylinositol 3-kinase (PI3-kinase subunit delta; PI3K-delta; PI3Kdelta), with potential antineoplastic activity. Upon oral administration linperlisib selectively binds to and inhibits PI3K-delta and prevents the activation of the PI3K/AKT signaling pathway. This decreases proliferation of and induces cell death in PI3K-delta over-expressing tumor cells. PI3K-delta also plays a key role in the B-cell receptor (BCR) signaling pathway and the proliferation of certain hematologic cancer cells. The targeted inhibition of PI3K-delta is designed to preserve PI3K signaling in normal, non-neoplastic cells, thereby minimizing serious side effects.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide
    2.1.2 InChI
    InChI=1S/C28H37FN6O5S/c1-28(2,36)20-5-7-34(8-6-20)17-19-13-21(29)15-22-24(31-27(32-25(19)22)35-9-11-40-12-10-35)18-14-23(33-41(4,37)38)26(39-3)30-16-18/h13-16,20,33,36H,5-12,17H2,1-4H3
    2.1.3 InChI Key
    NVWKNQGHVMMAJW-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC(C)(C1CCN(CC1)CC2=C3C(=CC(=C2)F)C(=NC(=N3)N4CCOCC4)C5=CC(=C(N=C5)OC)NS(=O)(=O)C)O
    2.2 Other Identifiers
    2.2.1 UNII
    05HYK3CV9N
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 1702816-75-8

    2. Pi3kdelta-in-2

    3. Pi3k(delta)-in-2

    4. 05hyk3cv9n

    5. Yy-20394

    6. Pi3k

    7. A-in-2

    8. N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide

    9. Methanesulfonamide, N-(5-(6-fluoro-8-((4-(1-hydroxy-1-methylethyl)-1-piperidinyl)methyl)-2-(4-morpholinyl)-4-quinazolinyl)-2-methoxy-3-pyridinyl)-

    10. N-(5-(6-fluoro-8-((4-(2-hydroxypropan-2-yl) Piperidin-1-yl)methyl)-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-)methanesulfonamide

    11. Linperlisib [inn]

    12. Pi3kd-in-2

    13. Pi3ko-in-2

    14. Unii-05hyk3cv9n

    15. Pi3k.delta.-in-2

    16. Linperlisib [who-dd]

    17. Pi3k -in-2

    18. Chembl4574601

    19. Schembl18032489

    20. Gtpl10466

    21. Us9656996, Compound 10

    22. Bdbm309960

    23. Bcp20830

    24. Ctc81675

    25. Ex-a1436

    26. Pi3k(c)(1/2)-in-2

    27. Cs-6973

    28. Yy20394

    29. Compound 10 [us20160244432]

    30. Yy-20394; Pi3k

    31. A-in-2

    32. Ac-35638

    33. Hy-102031

    34. N-[5-[6-fluoro-8-[[4-(1-hydroxy-1-methylethyl)-1-piperidinyl]methyl]-2-(4-morpholinyl)-4-quinazolinyl]-2-methoxy-3-pyridinyl]-methanesulfonamide

    2.4 Create Date
    2015-05-04
    3 Chemical and Physical Properties
    Molecular Weight 588.7 g/mol
    Molecular Formula C28H37FN6O5S
    XLogP32.1
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count12
    Rotatable Bond Count8
    Exact Mass588.25301764 g/mol
    Monoisotopic Mass588.25301764 g/mol
    Topological Polar Surface Area138 Ų
    Heavy Atom Count41
    Formal Charge0
    Complexity958
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1